Cargando…
Vasoprotective effects of human CD34+ cells: towards clinical applications
BACKGROUND: The development of cell-based therapeutics for humans requires preclinical testing in animal models. The use of autologous animal products fails to address the efficacy of similar products derived from humans. We used a novel immunodeficient rat carotid injury model in order to determine...
Autores principales: | Kiernan, Thomas J, Boilson, Barry A, Witt, Tyra A, Dietz, Allan B, Lerman, Amir, Simari, Robert D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724497/ https://www.ncbi.nlm.nih.gov/pubmed/19640275 http://dx.doi.org/10.1186/1479-5876-7-66 |
Ejemplares similares
-
Differential phenotype and behavior in culture of CD34 positive cells from peripheral blood and adipose tissue
por: Froehlich, Harald, et al.
Publicado: (2021) -
Pleiotropic vasoprotective effects of statins: The chicken or the egg?
por: Kirmizis, Dimitrios, et al.
Publicado: (2009) -
Novel Insights into the Vasoprotective Role of Heme Oxygenase-1
por: Marcantoni, Emanuela, et al.
Publicado: (2012) -
The pleiotropic vasoprotective functions of high density lipoproteins (HDL)
por: Boyce, Guilaine, et al.
Publicado: (2018) -
Xenoantigenicity of porcine decellularized valves
por: Helder, Meghana R. K., et al.
Publicado: (2017)